Results 91 to 100 of about 465 (157)

Multicenter Real-World Study: 432 Patients with Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer. [PDF]

Curr Oncol
Encarnación Navarro JA, Morillo Macías V, Borrás Calbo M, De la Fuente Muñoz I, Lozano Martínez A, García Martínez V, Fernández Fornos L, Guijarro Roche M, Amr Rey O, García Gómez R.   +9 more
europepmc   +1 more source

The comparison of outcomes between neoadjuvant novel and classical hormonal therapy in patients with locally advanced prostate cancer: a retrospective study. [PDF]

BMC Urol
Yang Z, Liu Y, Shao Y, Wu Y, Wang Y, Guo J, Liu Z, Huang H, Tian J, Niu Y, Wen S.   +10 more
europepmc   +1 more source

Risks of thrombosis and hemorrhage in concurrent use of anticoagulants and potential interacting prostate cancer agents. [PDF]

Cancer
Wang TF, Clarke A, Rath M, Yoo S, Fremont D, Wu C, Ravani P, Bossé D, Talarico R, Carrier M, Sood MM.   +10 more
europepmc   +1 more source

Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy. [PDF]

Eur Urol Oncol
Juarez Casillas JE, Nikitas J, Rettig MB, Reiter RE, Lee A, Steinberg ML, Valle L, Kalbasi TR, Calais J, Czernin J, Eala MA, Tsai S, Kane N, Solanki AA, Sexton R, Duriseti S, Berenji GR, Aronson WJ, Garraway IP, Chang MG, Kwon R, Lee SP, Nickols NG, Kishan AU.   +23 more
europepmc   +1 more source

The impact of androgen receptor pathway inhibitors as starting treatment in metastatic castration-sensitive prostate cancer on patient outcomes (OASIS Japan). [PDF]

Sci Rep
Shiota M, Liu Y, Mundle S, Nematian-Samani M, Hwang J, Wang X, Uemura H.   +6 more
europepmc   +1 more source

Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database. [PDF]

Urol Oncol
Eule CJ, Kuna EM, Robin TP, Gershman B, Flaig TW, Kim SP.   +5 more
europepmc   +1 more source

Synthesis of Thiohydantoin. III

Synthesis of Thiohydantoin. III
openaire  

Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials. [PDF]

JAMA Netw Open
Roy S, Ozay ZI, Guha A, Sun Y, Chi KN, Morgan SC, Malone S, Wallis CJD, Brown JR, Barata PC, Kishan AU, Jia AY, Zaorsky NG, Swami U, Chowdhury S, Small EJ, Spratt DE, Saad F, Agarwal N.   +18 more
europepmc   +1 more source

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer. [PDF]

Nat Commun
Roy S, Sun Y, Hussain M, Chi KN, Fizazi K, Davis ID, Halabi S, Agarwal N, Chowdhury S, Tombal B, Morgan SC, Malone S, Barata PC, Ong M, Wallis CJD, Berlin A, Swami U, Kishan AU, Jia AY, Zaorsky NG, Garcia JA, Mendiratta P, Brown JR, Subhash VV, Stockler MR, Thomas H, McKay RR, Small EJ, Shore ND, Saad F, Sweeney CJ, Spratt DE.   +31 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Staudinger Condensation for the Preparation of Thiohydantoins

Synthesis, 2014
An efficient one-pot, two-step sequence starting from azide derivatives is described: first, formation of iminophosphoranes (Staudinger reaction) and condensation with carbon disulfide to form nonisolated isothiocyanates; then, condensation with α-amino esters to provide new N-3-substituted 2-thiohydantoins.
Chahrazade El Amri, Arnaud Tatibouët
exaly   +2 more sources